(19)
(11) EP 3 638 700 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.09.2024 Bulletin 2024/36

(45) Mention of the grant of the patent:
24.07.2024 Bulletin 2024/30

(21) Application number: 18818346.1

(22) Date of filing: 13.06.2018
(51) International Patent Classification (IPC): 
C07K 16/46(2006.01)
C12N 15/13(2006.01)
A61P 35/00(2006.01)
 C07K 19/00(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 14/5428; C07K 14/55; C07K 14/56; C07K 14/565; C07K 14/57; C07K 2319/00; C07K 2319/70; C07K 16/00; C07K 16/2863; C07K 16/303; C07K 16/3092; C07K 16/32; C07K 16/40; A61K 2039/505; C07K 2317/22; C07K 2317/526; C07K 2317/569; C07K 2317/622; C07K 2317/64; C07K 2317/732; C07K 2317/92; C07K 2319/30
(86) International application number:
PCT/CN2018/091107
(87) International publication number:
WO 2018/228442 (20.12.2018 Gazette 2018/51)

(54)

PROTEINACEOUS HETERODIMER AND USE THEREOF

PROTEINÖSE HETERODIMER UND VERWENDUNG DAVON

HÉTÉRODIMÈRE PROTÉIQUE ET UTILISATION DE CELUI-CI

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.06.2017 WO PCT/CN2017/088344

(43) Date of publication of application:
22.04.2020 Bulletin 2020/17

(73) Proprietor: Shihuida Pharmaceutical Group (Jilin) Co., Ltd., a China corporation
Baishan City, 134399 Jilin Province (CN)

(72) Inventors:
  • XU, Ting
    Jiangsu 215125 (CN)
  • LUAN, Yan
    Jiangsu 215125 (CN)
  • PENG, Jianjian
    Jiangsu 215125 (CN)
  • FU, Kai
    Jiangsu 215125 (CN)
  • ZHAO, Meng
    Jiangsu 215125 (CN)
  • WANG, Xiaoxiao
    Jiangsu 215125 (CN)

(74) Representative: Weickmann & Weickmann PartmbB 
Postfach 860 820
81635 München
81635 München (DE)


(56) References cited: : 
WO-A1-2012/058768
WO-A1-2013/157954
WO-A1-2016/082677
WO-A1-2017/101828
WO-A2-2015/033223
CN-A- 102 558 355
 WO-A1-2013/157953
WO-A1-2013/166594
WO-A1-2016/082677
WO-A2-2014/012085
CN-A- 102 558 355
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).